
1. microbiome. 2018 sep 1;6(1):151. doi: 10.1186/s40168-018-0529-x.

detecting eukaryotic microbiota single-cell sensitivity human tissue.

lager s(1)(2), de goffau mc(3), sovio u(1)(2), peacock sj(3)(4)(5), parkhill
j(3), charnock-jones ds(1)(2), smith gcs(6)(7).

author information: 
(1)department obstetrics gynaecology, university cambridge, national
institute health research cambridge biomedical research centre, cambridge,
uk.
(2)centre trophoblast research (ctr), department physiology, development
and neuroscience, university cambridge, cambridge, uk.
(3)wellcome trust sanger institute, cambridge, uk.
(4)department medicine, university cambridge, cambridge, uk.
(5)london school hygiene tropical medicine, london, uk.
(6)department obstetrics gynaecology, university cambridge, national
institute health research cambridge biomedical research centre, cambridge,
uk. gcss2@cam.ac.uk.
(7)centre trophoblast research (ctr), department physiology, development
and neuroscience, university cambridge, cambridge, uk. gcss2@cam.ac.uk.

erratum in
    microbiome. 2018 oct 20;6(1):188.

background: fetal growth restriction, pre-eclampsia, pre-term birth major
adverse pregnancy outcomes. complications considerable contributors 
fetal/maternal morbidity mortality worldwide. significant proportion of
these cases thought due dysfunction placenta. however, the
underlying mechanisms placental dysfunction unclear. aim the
present study investigate whether adverse pregnancy outcomes are
associated evidence placental eukaryotic infection.
results: modified 18s illumina amplicon protocol earth microbiome
project made capable detecting single spiked-in genome copy of
plasmodium falciparum, saccharomyces cerevisiae, toxoplasma gondii among 
than 70,000 human cells. using method, unable detect eukaryotic
pathogens placental biopsies instances adverse pregnancy outcome
(n = 199) healthy controls (n = 99).
conclusions: eukaryotic infection placenta underlying cause of
the aforementioned pregnancy complications. possible clinical applications for
this non-targeted, yet extremely sensitive, eukaryotic screening method are
manifest.

doi: 10.1186/s40168-018-0529-x 
pmcid: pmc6119588
pmid: 30172254  [indexed medline]

